d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19

Since the outbreak of coronavirus disease 2019 (COVID-19), biomarkers for evaluating severity, as well as supportive care to improve clinical course, remain insufficient. We explored the potential of d-amino acids, rare enantiomers of amino acids, as biomarkers for assessing disease severity and as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura-Ohba, Shihoko, Asaka, Masamitsu N., Utsumi, Daichi, Takabatake, Yoshitsugu, Takahashi, Atsushi, Yasutomi, Yasuhiro, Isaka, Yoshitaka, Kimura, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584837/
https://www.ncbi.nlm.nih.gov/pubmed/36280155
http://dx.doi.org/10.1016/j.bbadis.2022.166584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584837/
https://www.ncbi.nlm.nih.gov/pubmed/36280155
http://dx.doi.org/10.1016/j.bbadis.2022.166584

Ejemplares similares